Skip to main content
. 2020 Aug 9;12(8):511. doi: 10.3390/toxins12080511
AE adverse event
AUC area under the curve
bpm beats per minute
Cmax maximum plasma concentration
CI confidence interval
C-QTc corrected concentration-QT interval
CV% coefficient of variance
hERG Human Ether-à-go-go-Related Gene
ICH E14 International Conference on Harmonization E14 guidance
PK pharmacokinetics
QTcF Fridericia corrected QT interval
ΔQTcF Baseline adjusted Fridericia-corrected QTc
ΔΔQTcF Baseline and placebo adjusted Fridericia-corrected QTc
TEAE treatment emergent adverse event
tmax time at Cmax
TTX tetrodotoxin
VGSC voltage-gated sodium channel